- Companion animal vaccines are essential for preventing a wide range of diseases in pets, such as dogs, cats, and horses. These vaccines play a crucial role in ensuring the health and longevity of companion animals by providing immunity against infectious diseases
- The demand for companion animal vaccines is driven by increasing pet ownership, rising awareness of preventive healthcare, and advancements in vaccine technology, including more effective and longer-lasting vaccines
- North America is expected to dominate the companion animal vaccines market with a market share of 40.5%, due to high pet ownership, a well-established veterinary healthcare system, and strong demand for advanced preventive care for pets
- Asia Pacific is expected to be the fastest growing region in the companion animal vaccines market with a market share of 23.5%, during the forecast period due to rapid expansion in healthcare infrastructure, increasing awareness about pet health, and rising pet ownership in the region
- Attenuated Live Vaccines segment is expected to dominate the market with a market share of 37.5% due to its ability to induce strong, long-lasting immune responses with fewer doses. These vaccines closely mimic natural infections, offering superior protection
